Directory · SE
Pharmaceutical Manufacturing in Sweden
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Sweden. Browse the public index, then filter or export on Kipplo.
Companies
280 on file
Lantheus
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in Canada and Sweden.
501 to 1000 staff
Apoteket Ab
Apoteket är Sveriges ledande apoteksaktör och ett av landets mest omtyckta varumärken. Kombinationen av lång historia, hållbart företagande och innovation,gör oss till ett dynamiskt företag där vi bidrar till ett liv i hälsa. Vi erbjuder ett brett utbud av läkemedel, noga utvalda hälsoprodukter och farmaceutiska tjänster till konsumenter och vården. Alltid tillsammans och mot ett gemensamt mål. Har du kunskap inom farmaci eller en passion för affärsutveckling? Är du teknikexpert, jurist, ekonomisk strateg, säkerhetskunnig, engagerad projektledare eller läkemedelsansvarig? Hos oss finns många möjligheter att växa och uvecklas. Oavsett vilken bransch eller roll du är verksam i idag hoppas vi att du blir nyfiken på oss.
1001 to 5000 staff
Immedica Pharma Ab
About Immedica Pharma Immedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Welcome to the Immedica social media channels The Immedica social channels are set up to share news, updates, and company happenings with all visitors. Please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy. Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly. Examples of reasons for having a comment removed from a post on our social media might be- References a side effect or complaint - Reporting of an adverse event, side effect or reaction from an Immedica product (that information should be reported directly to Immedica Drug Safety or to your physician.)- A reference to a product or treatment We work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice - your doctor or health care provider is the person to ask. If you have a product enquiry, please email the Immedica medical department- Abusive language We welcome your feedback, provided that you share your view in a way that is respectful to our community, meaning not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.
51 to 200 staff
Doz Apotek
DOZ Apotek är Sveriges nyaste apotek men vår historia går långt tillbaka. Vi öppnade vårt första apotek i Eskilstuna 2010 under namnet Doc Morris och har sedan dess vuxit med etableringar. Idag har vi 74 fysiska apotek runtom i landet samt en komplett e-handel med ett stort e-handelsapotek beläget i Stockholm. Hos oss hittar du ca. 450 engagerade medarbetare men såklart även läkemedel och egenvårdsprodukter. Mellan 2013 – 2022 hittade du oss under namnet LloydsApotek men sommaren 2021 förvärvades LloydsApotek av CEPD N.V.(Corporation of European Pharmaceutical Distributors N.V.) som är ett internationellt holdingbolag och ett av de ledande företagen på Europas läkemedelsmarknad. CEPD förvaltar den femte största apotekskedjan i Europa och grundades 2008. CEPD är en erfaren och kunnig hälsovårdsaktör i Europa med huvudkontor i Amsterdam, Nederländerna. CEPD N.V.s mission är att förse kunder med apotekstjänster av högsta kvalitet och ett brett utbud av prisvärda produkter baserat på en innovativ och modern strategi för distribution och läkemedelsförsäljning. Under hösten 2022 lämnade vi namnet LloydsApotek till DOZ Apotek, namnet delar vi tillsammans med den femte största apotekskedjan i Europa med över 1300 apotek i Polen och Litauen. Begreppet DOZ kommer från det polska begreppet dbam o zdrowie, vilket betyder: Jag bryr mig om min hälsa.
501 to 1000 staff
Northx Biologics
Nestled in Sweden's life sciences heartland, NorthX Biologics has been at the forefront of biologics manufacturing and process development since 1992. Our rich heritage in Good Manufacturing Practice (GMP) is not just a testament to our enduring commitment to quality but also to the trust that the biotech community has placed in us for more than three decades. Our expertise within bioprocessing spans a variety of advanced modalities, including recombinant proteins, viral vaccines and cell therapy, supporting projects from concept through to commercial manufacturing offering a full spectrum of GMP-compliant services. It is our relentless pursuit of excellence and innovation that led to our recognition in 2021 as a national innovation hub for advanced therapeutics and vaccines by the Swedish Government, a milestone that underscores our role in shaping the future of healthcare. We are more than a CDMO; we are pioneers and partners in the truest sense. At NorthX Biologics, we believe in embarking on a collaborative journey with our clients, navigating the complexities of biologics and growing along the way. Let's journey together to turn visionary science into life-changing treatments. We specialise in: Process development Analytical development Recombinant proteins Virus & Vectors Cell Therapy Extracellular Vesicles Aseptic fill & finish Microbial & mammalian production QC, QA, QP
51 to 200 staff
Optimapharm
Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives. Optimapharm’s key priorities are our people and consistently exceeding our client’s expectations. With 26 strategically located offices across Europe, Optimapharm gives unrivalled access to Patients and Investigators worldwide. In-depth expertise and long-standing experience, combined with a flexible and collaborative approach, allow optimization of design and planning; through its strong track record of delivery excellence and committed and stable project teams, Optimapharm has secured a high level of repeat business over the years. Companies Figures • 510+ staff members • Excellence in delivery and superior project performance with an investigator network of active sites • Close client relationship & high client retention rate of 85% • Highly educated workforce & low staff turnover rate; less than 15%, across the organization • Regional Cost-effective solutions Full-service study delivery, Stand-alone service and Functional Service Provider are the 3 pillars Optimapharm offers to best respond to planned clinical development and efficiently resource clinical projects. • Regulatory Affairs • Medical Affairs • Medical Writing • Clinical Monitoring • Project Management • Data Management • Biostatistics • Safety and Vigilance • Quality • Translation Services OPTIMAPHARM's offices- Austria - Belgium - Bosnia and Herzegovina - Bulgaria - Croatia - Czech Republic - Estonia - Finland - France - Georgia - Germany - Greece - Hungary - Lithuania - Republic of North Macedonia - Moldova - Poland - Romania - Serbia - Slovenia - Spain - Sweden - Switzerland - The United Kingdom - The United States of America
501 to 1000 staff
Astrazeneca
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit Community Guidelines: bit.ly/2MgAcio
10001+ staff
Gedeon Richter Nordics Ab
Gedeon Richter Nordics AB is a pharmaceutical company with a focus on gynecology and women's health. The company has 24 employees in the Nordic region and the Nordic headquarters is in Stockholm. Gedeon Richter Nordics AB is a wholly owned subsidiary of Gedeon Richter Plc with headquarters in Budapest, Hungary. The company is one of Eastern Europe's largest multinational pharmaceutical companies with research in gynecology, the central nervous system and the cardiovascular field. Through the purchase of Swiss PregLem, German Grünenthal women's health products and Swiss Finox, the company is expanding in Western Europe, primarily in gynecology.
11 to 50 staff
Iconovo Ab
Iconovo develops new inhaled medicinal products in collaboration with international pharmaceutical companies. We have several types of patented dry powder inhalers that can create significant commercial opportunities for the development of both new pharmaceuticals and generic medicine. Our strength is our inhouse capabilities with full control over both device development and formulation, meaning less risk and faster time to market.
11 to 50 staff
Keyplants
About us KeyPlants, headquartered in Stockholm, Sweden, is a leader in the off-site manufacturing space for the life science industry, having executed 100+ projects globally. Our customers benefit from KeyPlants’ vast experience and expertise, resulting in 30-50% shorter timelines and increased predictability with regards to schedule, cost, and quality. KeyPlants deliver pods and turnkey facilities including process equipment, utilities, and digital solutions.
51 to 200 staff
Apoex
ApoEx grundades 2010 i syfte att förenkla och förbättra vården. Sedan dess har tusentals vårdföretag inom privat och offentlig sektor valt ApoEx som sin strategiska partner avseende försörjning av läkemedel och förbrukningsmaterial. Verksamheten kännetecknas av kunddriven innovation och attityden att ingenting är omöjligt. Vill du utvecklas med oss? Läs mer om ApoEx på
201 to 500 staff
Apoteksgruppen
Från och med den 1 april 2025 har Apoteksgruppen gått samman med Kronans Apotek i ett och samma bolag. Följ oss vidare på Kronans Apotek för nyheter, jobbannonser och inspiration! https://karriar.kronansapotek.se/
1001 to 5000 staff
Kronans Apotek
Kronans Apotek är Sveriges största apotekskedja sett till antal apotek. Vi är närvarande i hela Sverige med våra närmare 500 apotek, en tillgänglig e-handel och drygt 3 500 medarbetare – så att du enkelt kan handla och få professionell rådgivning när det passar dig. Med kompetens, omtanke, tjänster och ett brett sortiment hjälper vi fler att må bättre och få ut mer av livet. 🧡
1001 to 5000 staff
Magle Chemoswed
We are a CDMO based in Malmö, Sweden, that serves companies in the pharmaceutical and medical device industry. We provide comprehensive services from development through manufacturing on a contract basis. Together with our partners, we take innovations from idea to product.
51 to 200 staff
Msd Sverige
MSD Sveriges officiella LinkedIn. Om oss: Frågor om MSD läkemedel: medicinskinfo@msd.com. Biverkansrapportering: pv.sweden@msd.com.
51 to 200 staff
Oncopeptides Ab Publ
Oncopeptides is a Swedish biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Conjugate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. Its flagship drug, Pepaxti, is currently being commercialized in Europe with partnership agreements for South Korea, the Middle East and Africa and elsewhere. Oncopeptides is also developing several new compounds based on its two proprietary technology platforms PDC and SPiKE. The company was founded in has about 80 employees with operations in Sweden, Germany, Austria, Spain and Italy. Oncopeptides is listed on Nasdaq Stockholm with the ticker ONCO. For more information, visit:
51 to 200 staff
Ondosis
We believe that everyone deserves a good life, and for some that is only possible when the medicine is just right. Therefore we are writing a new chapter in personalized medicine. OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. OnDosis is currently developing products for individualized dosing to help 100's of thousands of patients diseases with a significant unmet needs such as ADHD, food allergies, pain and immunosuppression for organ transplants. OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered at GoCo House in Gothenburg, Sweden.
11 to 50 staff
Sobi - Swedish Orphan Biovitrum Ab Publ
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
1001 to 5000 staff
Vivesto Ab
Vivesto is a Swedish drug development company that aims to offer new treatment options for hard-to-treat cancers where there are major medical needs and significant market potential. The project portfolio consists of Cantrixil, which is being developed for blood cancer, and the veterinary oncology program Paccal Vet (paclitaxel micellar), which is being evaluated in a pilot clinical trial in dogs with splenic hemangiosarcoma following splenectomy and in a dose-finding study in cats with solid tumors. Vivesto’s shares are traded on Nasdaq Stockholm (ticker: VIVE). To find out more about Vivesto please visit
1 to 10 staff
Bluefish Pharmaceuticals
Founded in Sweden, with its long tradition of industrial entrepreneurship, Bluefish Pharmaceuticals has become one of the most progressive generics pharmaceuticals companies. At Bluefish, we strive to make quality medicines accessible to more people. We create value in the full pharmaceutical value chain from developing to manufacturing and successfully marketing generic pharmaceuticals and we take pride in doing this in an innovative, responsible and cost-efficient way. Bluefish currently conducts operations in 19 countries in Europe and, over the next few years, will also expand outside Europe with the aim of becoming a global player. Our corporate culture and close collaboration with development and manufacturing partners are integral parts of our effort to deliver quality products at affordable prices. We offer a product portfolio consisting of a broad range of high quality generics for all major therapeutic areas. It is part of our long-term strategy to expand the product portfolio of off-patent blockbusters while at the same time offering a broader range of niche products within more narrow disease areas.
51 to 200 staff
Diamyd Medical
Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for the prevention and treatment of autoimmune diabetes. The investigational flagship product Diamyd® is a disease-modifying antigen-specific immunotherapy for the preservation of endogenous insulin production that has Orphan Drug Designation in the U.S. and has been granted Fast Track designation by the U.S. FDA. DIAGNODE-3, a confirmatory Phase trial is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the U.S. Diamyd Medical’s shares are traded on Nasdaq First North Growth Market, ticker DMYD B.
11 to 50 staff
Medivir Ab
Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a smart, targeted chemotherapy designed to selectively treat liver cancer cells and to minimize side effects. Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Medivir's share (ticker: MVIR) is listed on Nasdaq Stockholm's Small Cap list.
1 to 10 staff
Niconovum Ab
Niconovum was formed in by Dr. Karl Olof Fagerström, one of the world’s leading experts on smoking cessation and nicotine dependence. Niconovum believes there is a need for a range of Nicotine Replacement Therapy (NRT) products that deliver nicotine efficiently and pleasantly – giving consumers better options to choose from in order to meet their personal tobacco reduction goals. Niconovum currently markets NRT products under the Zonnic brand in Sweden, Norway, Finland and Iceland. In 2009, Niconovum was acquired by Reynolds American Inc.(RAI) and in 2017, RAI was acquired by British American Tobacco (BAT). BAT has a stated ambition to lead the transformation of the tobacco industry by offering adult consumers a range of potentially reduced-risk products.
11 to 50 staff
Cambrex Karlskoga Ab
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides comprehensive analytical and IND enabling services, as well as drug substance development and manufacturing across the entire drug lifecycle. With over 40 years of experience and a team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API development and manufacturing.
201 to 500 staff
